Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CASP1 | P29466 | 1/20 | 0.62 |
| ▸ | TACR3 | P29371 | 2/20 | 0.62 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.57 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.57 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.57 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.57 |
| ▸ | HPGDS | O60760 | 1/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.50 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.50 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.50 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.49 |
| ▸ | MEN1 | O00255 | 2/20 | 0.49 |
| ▸ | POLB | P06746 | 1/20 | 0.49 |
| ▸ | HPGD | P15428 | 2/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.49 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.49 |
| ▸ | HTT | P42858 | 3/20 | 0.49 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.49 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10134740 | 0.86 | HPGD (0.49) | CASP1TACR3KMT2ACYP2C19CYP2C9 | |
| SCHEMBL10134751 | 0.84 | KDM4E (0.65) | KMT2AKDM4EPOLBHPGDALDH1A1 | |
| SCHEMBL12359370 | 0.80 | TACR3 (0.61) | CASP1TACR3CHRNB2CHRNB4CHRNA3 | |
| SCHEMBL12024779 | 0.78 | HPGDS (0.55) | TACR3CHRNB2CHRNB4CHRNA3CHRNA4 | |
| SCHEMBL6450086 | 0.77 | TACR3 (1.00) | TACR3KMT2ACYP3A4CYP2C9KDM4E | |
| SCHEMBL10134744 | 0.74 | PDE2A (0.52) | CASP1KMT2ACYP2C9ALDH1A1HTT | |
| SCHEMBL12391553 | 0.73 | HTT (0.59) | TACR3CHRNB2CHRNB4CHRNA3CHRNA4 | |
| SCHEMBL31680569 | 0.72 | KMT2A (0.89) | CHRNB2CHRNB4CHRNA3CHRNA4KMT2A | |
| SCHEMBL11901003 | 0.72 | KMT2A (0.89) | CHRNB2CHRNB4CHRNA3CHRNA4KMT2A | |
| SCHEMBL12142857 | 0.71 | NSD2 (0.66) | KMT2AKDM4EMEN1HPGDMAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8703770-B2 | Pyridazine carboxamide orexin receptor antagonists | MERCK SHARP & DOHME CORP. (US) | 2014-04-22 | — | — | US | disclosed |
| US-20120046289-A1 | Pyridazine Carboxamide Orexin Receptor Antagonists | MERCK SHARP & DOHME CORP. | 2012-02-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120046289-A1 | Pyridazine Carboxamide Orexin Receptor Antagonists | HCRTR2, HCRTR1, NPY5R | CASP1 2747/4885TACR3 234/4885CHRNB2 228/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.